CEDAR is proud to be a co-founding partner of the International Alliance for Cancer Early Detection, or ACED, a $70 million partnership with other world-leading centers for cancer early detection research: the Canary Center at Stanford for Cancer Early Detection, the University of Cambridge, University College London and the University of Manchester. By uniting some of the best scientific talent from across the world, the Alliance aims to accelerate and revolutionize research in this profoundly important field, leading to improved cancer early detection, diagnosis, and prevention of its progression to meaningfully benefit people at high risk of cancer.
As part of ACED, CEDAR/OHSU is spearheading the Integrated Data Platform to provide access to research data across the Alliance. We are also leveraging our strengths in single cell analysis, biofabrication, and proteomics, with collaborative projects for early detection across the centers.
Want to learn more?
You can learn more about ACED, including information on its aims, scientific strategy, training and development programs, and funding opportunities, at the Alliance's website. We'll be introducing new opportunities to work with the Alliance as it develops.
The ACED Welcome Packet provides more helpful information about navigating ACED at OHSU, including how to get involved, how to initiate research projects, and how to become a member.
Contact CEDAR's Zach Miller with any questions concerning ACED.